Centiva Capital’s Omnicell OMCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-21,396
Closed -$748K 1921
2025
Q1
$748K Buy
+21,396
New +$848K 0.02% 608
2024
Q4
Sell
-5,049
Closed -$220K 2196
2024
Q3
$220K Sell
5,049
-19,341
-79% -$729K ﹤0.01% 1769
2024
Q2
$660K Sell
24,390
-481
-2% -$13.9K 0.01% 991
2024
Q1
$727K Buy
24,871
+5,181
+26% +$157K 0.02% 817
2023
Q4
$741K Buy
19,690
+10,725
+120% +$394K 0.02% 765
2023
Q3
$404K Buy
+8,965
New +$543K 0.01% 1056
2021
Q2
Sell
-3,410
Closed -$443K 1556
2021
Q1
$443K Buy
3,410
+410
+14% +$52.6K 0.02% 613
2020
Q4
$360K Buy
+3,000
New +$294K 0.01% 592

Other funds holding OMCL

Centiva Capital's OMCL Position: Q2 2025 in Review

Centiva Capital sold out of Omnicell (OMCL) in Q2 2025, closing a stake of 21,396 shares — an estimated $748K sold.

Centiva Capital first reported a position in OMCL in Q4 2020 and held it in 8 quarters. The position peaked at $748K in Q1 2025. 247 funds tracked by Wall St. Rank hold OMCL as of Q2 2025.

  • Centiva Capital reported no remaining Omnicell position as of Q2 2025 after selling out during the quarter.
  • Centiva Capital sold 21,396 Omnicell shares in Q2 2025, an estimated $748K.
  • Centiva Capital first reported a position in Omnicell in Q4 2020 and held it in 8 quarters.
  • Centiva Capital's Omnicell position peaked at $748K in Q1 2025.
  • 247 funds tracked by Wall St. Rank held Omnicell as of Q2 2025.

Based on Centiva Capital's 13F filing for Q2 2025, filed 13 Aug 2025.